Business
Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference
Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Piper Sandler 37th Annual Healthcare Conference:
About this update from Indivior Pharmaceuticals, Inc.
[{"type":"text","content":"RICHMOND, Va., Nov. 19, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Piper Sandler 37th Annual Healthcare Conference:","length":174,"tagName":"p"},{"type":"image","alt":"Indivior (PRNewsfoto/Indivior)","displaySize":"","headline":null,"caption":"Indivior (PRNewsfoto/Indivior)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":130,"url":"https://media.zenfs.com/en/prnewswire.com/e9a6eb17aaf44dddfab6f7d13d2315b7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.uJSnzZQQuSzYp3kZpAAsQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIyOTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/e9a6eb17aaf44dddfab6f7d13d2315b7","width":400,"height":130}},"href":"https://mma.prnewswire.com/media/1814851/Indivior_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"list","items":[{"val":[{"type":"text","content":"Piper Sandler 37th Annual Healthcare Conference – New York City, NYJoe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Tuesday, December 2nd. Joe Ciaffoni and Ryan Preblick will also participate in a fireside discussion on Tuesday, December 2nd at 3:30 p.m. U.S. EST. Interested investors should contact their Piper Sandler representative to schedule a meeting.The fireside discussion will be publicly available and can be viewed using the following weblink: Piper Sandler Fireside Chat Live Webcast.","length":579,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":579,"olType":false},{"type":"text","content":"About Indivior Indivior Pharmaceuticals works to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a human crisis to a recognized and treated chronic disease. Building on its portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/Indivior.","length":618,"tagName":"p"},{"type":"image","alt":"Cision","displaySize":"","headline":null,"caption":"Cision","className":"","disableSlideshowImg":fals...